A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain

Pain Research and Management

Volumn 16, Issue 5, 2011, Pages 337-351

  Furlan, Andrea D ^a,b,c   Chaparro, Luis E ^d   Irvin, Emma ^a   Mailis Gagnon, Angela ^c,d  

^a INSTITUTE FOR WORK AND HEALTH   (Canada)

^b TORONTO REHABILITATION INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Chronic pain; Enriched design; Meta analysis; Opioids; Systematic review

Indexed keywords

BUPRENORPHINE; CLOMIPRAMINE; CODEINE; DEXTROPROPOXYPHENE; DICLOFENAC; FENTANYL; GABAPENTIN; LEVOMEPROMAZINE; METHADONE; MORPHINE; NALTREXONE; NAPROXEN; NORTRIPTYLINE; OPIATE; OXYCODONE; OXYMORPHONE; PARACETAMOL; SUPROFEN; TRAMADOL; NARCOTIC ANALGESIC AGENT;

ABDOMINAL PAIN; ANALGESIA; ANOREXIA; ANXIETY; APPLICATION SITE REACTION; ARTHRALGIA; ATAXIA; BLURRED VISION; CHRONIC LUMBAR RADICULOPATHY; CONFUSION; CONSTIPATION; DIABETIC NEUROPATHY; DIARRHEA; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRY SKIN; EDEMA; EMBASE; ENRICHED ENROLLMENT RANDOMIZED WITHDRAWAL DESIGN; FATIGUE; FIBROMYALGIA; HEADACHE; HEARTBURN; HIP OSTEOARTHRITIS; HOT FLUSH; HUMAN; INSOMNIA; KNEE OSTEOARTHRITIS; LOW BACK PAIN; MEDLINE; META ANALYSIS; MUSCLE CONTRACTION; MUSCULOSKELETAL PAIN; NAUSEA; NEUROPATHIC PAIN; NOCICEPTIVE PAIN; NONENRICHED ENROLLMENT RANDOMIZED WITHDRAWAL DESIGN; OSTEOARTHRITIS; PAIN; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; PHANTOM PAIN; POLYNEUROPATHY; POSTAMPUTATION PAIN; POSTHERPETIC NEURALGIA; QUALITY OF LIFE; RADICULOPATHY; REVIEW; RHEUMATOID ARTHRITIS; SEXUAL DYSFUNCTION; SIDE EFFECT; SKIN PRURITUS; SOMNOLENCE; STUDY DESIGN; SWEATING; SYSTEMATIC REVIEW; VOMITING; WEAKNESS; XEROSTOMIA; CHRONIC PAIN; RANDOMIZED CONTROLLED TRIAL (TOPIC); WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; CHRONIC PAIN; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84555196148     PISSN: 12036765     EISSN: None     Source Type: Journal    
DOI: 10.1155/2011/465281     Document Type: Review

References (77)

1. Straube S, Derry S, McQuay HJ, Moore RA. Enriched enrollment: Definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review. Br J Clin Pharmacol 2008;66:266-75.
2. McQuay HJ, Derry S, Moore RA, Poulain P, Legout V. Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain. Pain 2008;135:217-20.
3. Staud R, Price DD. Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can affect placebo factors. Pain 2008;136:232-4.
4. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects. CMAJ 2006;174:1589-94. (Pubitemid 43829515)
5. Furlan AD, Reardon R, Weppler C. Opioids for chronic noncancer pain: A new Canadian practice guideline. CMAJ 2010;182:923-30.
6. Repchinsky C. Table 2: Opioid Analgesics. Approximate analgesic equivalences. Compendium of Pharmaceutical Specialties. Ottawa: Canadian Pharmacists Association, 2004:457.
7. Higgins JPT, Green S. Assessing risk of bias in included studies. In: Higgins JPT, Altman DG, eds. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2008.
8. Cohen J. Statistical power analysis for the behavioral sciences. New York, San Francisco, London: Academic Press, 1988.
9. Kosinski M, Janagap C, Gajria K, Schein J, Freedman J. Pain relief and pain-related sleep disturbance with extended-release tramadol in patients with osteoarthritis. Curr Med Res Opin 2007;23:1615-26. (Pubitemid 47122171)
10. Gana TJ, Pascual ML, Fleming RR, et al. Extended-release tramadol in the treatment of osteoarthritis: A multicenter, randomized, double-blind, placebo-controlled clinical trial. Curr Med Res Opin 2006;22:1391-401. (Pubitemid 44085591)
11. Schein JR, Kosinski MR, Janagap-Benson C, Gajria K, Lin P, Freedman JD. Functionality and health-status benefits associated with reduction of osteoarthritis pain. Curr Med Res Opin 2008;24:1255-65. (Pubitemid 351741557)
12. Arkinstall W, Sandler A, Goughnour B, Babul N, Harsanyi Z, Darke AC. Efficacy of controlled-release codeine in chronic non-malignant pain: A randomized, placebo-controlled clinical trial. Pain 1995;62:169-78.
13. Babul N, Noveck R, Chipman H, Roth SH, Gana T, Albert K. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: A randomized 12-week clinical trial in osteoarthritis of the knee. J Pain Symptom Manage 2004;28:59-71. (Pubitemid 38829673)
14. Beaulieu AD, Peloso PM, Haraoui B, et al. Once-daily, controlled-release tramadol and sustained-release diclofenac relieve chronic pain due to osteoarthritis: A randomized controlled trial. Pain Res Manag 2008;13:103-10. (Pubitemid 351865292)
15. Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: A double-blind, randomized, placebo-controlled study. Am J Med 2003;114:537-45. (Pubitemid 36577256)
16. Boureau F, Boccard E. Placebo-controlled study of analgesic efficacy of 500mg paracetamol 30mg codeine association combined with a low dose of diclofenac versus high dose of diclofenac in rheumatoid arthritis. Acta Therapeutica 1991;17:123-36.
17. Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: A randomized, double-blind, placebo-controlled trial. Pain 2003;104:323-31. (Pubitemid 36835899)
18. Burch F, Fishman R, Messina N, et al. A comparison of the analgesic efficacy of Tramadol Contramid OAD versus placebo in patients with pain due to osteoarthritis. J Pain Symptom Manage 2007;34:328-38. (Pubitemid 47371077)
19. Caldwell JR, Rapoport RJ, Davis JC, et al. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: Results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage 2002;23:278-91. (Pubitemid 34462941)
20. Caldwell JR, Hale ME, Boyd RE, et al. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: A double blind, randomized, multicenter, placebo controlled trial. J Rheumatol 1999;26:862-9. (Pubitemid 29195674)
21. Chindalore VL, Craven RA, Yu KP, Butera PG, Burns LH, Friedmann N. Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: A randomized, controlled trial of Oxytrex. J Pain 2005;6:392-9. (Pubitemid 40804344)
22. Emkey R, Rosenthal N, Wu S-C, Jordan D, Kamin M. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: A multicenter, randomized, double-blind, placebo-controlled trial. J Rheumatol 2004;31:150-6. (Pubitemid 38067537)
23. Fleischmann RM, Caldwell JR, Roth SH, et al. Tramadol for the treatment of joint pain associated with osteoarthritis: A randomized, double-blinded, placebo-controlled trial. Curr Ther Res 2001;62:113-28. (Pubitemid 32222928)
24. Frank B, Serpell MG, Hughes J, Matthews JN, Kapur D. Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: Randomised, crossover, double blind study. BMJ 2008;336:199-201. (Pubitemid 351212676)
25. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005;352:1324-34. (Pubitemid 40411499)
26. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial. Neurology 2003;60:927-34. (Pubitemid 36348923)
27. Glowinski J, Boccard E. Placebo-controlled study of the analgesic efficacy of a paracetamol 500 mg/codeine 30 mg combination together with low-dose vs high-dose diclofenac in rheumatoid arthritis. Clin Drug Investig 1999;18:189-97. (Pubitemid 29457127)
28. Gobel H, Stadler TH. Treatment of pain due to postherpetic neuralgia with tramadol. Results of an open, parallel pilot study vs clomipramine with and without levomepromazine. Clin Drug Investig 1995;10:208-14.
29. Hale ME, Ahdieh H, Ma T, Rauck R. Efficacy and safety of OPANA ER (Oxymorphone Extended Release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: A 12-week, randomized, double-blind, placebo-controlled study. J Pain 2007;8:175-84. (Pubitemid 46186162)
30. Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998;50:1842-6. (Pubitemid 28283262)
31. Harke H, Gretenkort P, Ladleif HU, Rahman S, Harke O. The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: A double-blinded randomized study. Anesth Analg 2001;92:488-95. (Pubitemid 32127642)
32. Huse E, Larbig W, Flor H, Birbaumer N. The effect of opioids on phantom limb pain and cortical reorganization. Pain 2001;90:47-55. (Pubitemid 32146556)
33. Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain. A randomized prospective study. Spine 1998;23:2591-600.
34. Khoromi S, Cui L, Nackers L, Max MB. Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. Pain 2007;130:66-75.
35. Kivitz A, Ma C, Ahdieh H, Galer BS. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Clin Ther 2006;28:352-64. (Pubitemid 43783436)
36. Kjaersgaard-Andersen P, Nafei A, Skov O, et al. Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip. A randomised, double-blind, multi-centre study. Pain 1990;43:309-18.
37. Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: A multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study. Clin Ther 2007;29:2179-93. (Pubitemid 350148284)
38. Langford R, McKenna F, Ratcliffe S, Vojtassak J, Richarz U. Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: A randomized, placebo-controlled trial. Arthritis Rheum 2006;54:1829-37. (Pubitemid 43877932)
39. Lee EY, Lee EB, Park BJ, et al. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: A 1-week, randomized, double-blind, placebo-controlled trial. Clin Ther 2006;28:2052-60. (Pubitemid 46215752)
40. Ma K, Jiang W, Zhou Q, Du DP. The efficacy of oxycodone for management of acute pain episodes in chronic neck pain patients. Int J Clin Pract 2008;62:241-7.
41. Maier C, Hildebrandt J, Klinger R, Henrich-Eberl C, Lindena G; MONTAS Study Group. Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain - results of a double-blind placebo-controlled trial (MONTAS). Pain 2002;97:223-33. (Pubitemid 34607218)
42. Markenson JA, Croft J, Zhang PG, Richards P. Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial. Clin J Pain 2005;21:524-35. (Pubitemid 41527742)
43. Matsumoto AK, Babul N, Ahdieh H. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: Results of a randomized, double-blind, placebo- and active-controlled phase III trial. Pain Med 2005;6:357-66. (Pubitemid 41727333)
44. Moran C. MST continuous tablets and pain control in severe rheumatoid arthritis. Br J Clin Res 1991;2:1-12.
45. Moulin DE, Iezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H. Randomised trial of oral morphine for chronic non-cancer pain. Lancet 1996;347:143-7. (Pubitemid 26025152)
46. Norrbrink C, Lundeberg T. Tramadol in neuropathic pain after spinal cord injury: A randomized, double-blind, placebo-controlled trial. Clin J Pain 2009;25:177-84.
47. Parr G, Darekar B, Fletcher A, Bulpitt CJ. Joint pain and quality of life; results of a randomised trial. Br J Clin Pharmacol 1989;27:235-42. (Pubitemid 19059487)
48. Pavelka K, Peliskova Z, Stehlikova H, Ratcliffe S, Repas C. Intraindividual differences in pain relief and functional improvement in osteoarthritis with diclofenac or tramadol. Clin Drug Investig 1998;16:421-9. (Pubitemid 29012064)
49. Peloso PM, Fortin L, Beaulieu A, Kamin M, Rosenthal N. Analgesic efficacy and safety of tramadol/acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: A multicenter, outpatient, randomized, double blind, placebo controlled trial. J Rheumatol 2004;31:2454-63. (Pubitemid 39603097)
50. Peloso PM, Bellamy N, Bensen W, et al. Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee. J Rheumatol 2000;27:764-71. (Pubitemid 30151360)
51. Portenoy RK, Messina J, Xie F, Peppin J. Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: A randomized, placebo-controlled study. Curr Med Res Opin 2007;23:223-33. (Pubitemid 46191684)
52. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2002;59:1015-21.
53. Roth SH, Fleischmann RM, Burch FX, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: Placebo-controlled trial and long-term evaluation. Arch Intern Med 2000;160:853-60. (Pubitemid 30165247)
54. Roth SH. Efficacy and safety of tramadol HCl in breakthrough musculoskeletal pain attributed to osteoarthritis. J Rheumatol 1998;25:1358-63. (Pubitemid 28312355)
55. Ruoff GE. Slowing the initial titration rate of tramadol improves tolerability. Pharmacotherapy 1999;19:88-93. (Pubitemid 29031531)
56. Ruoff GE, Rosenthal N, Jordan D, Karim R, Kamin M; Protocol CAPS. Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: A multicenter, randomized, double-blind, placebo-controlled outpatient study. Clin Ther 2003;25:1123-41. (Pubitemid 36532582)
57. Russell J, Kamin M, Bennett RM, Schnitzer TJ, Green JA, Katz WA. Efficacy of tramadol in treatment of pain in fibromyalgia. J Clin Rheumatol 2000;6:250-7.
58. Salzman RT, Brobyn RD. Long-term comparison of suprofen and propoxyphene in patients with osteoarthritis. Pharmacology 1983;27(Suppl 1):55-64. (Pubitemid 14219727)
59. Schnitzer TJ, Gray WL, Paster RZ, Kamin M. Efficacy of tramadol in treatment of chronic low back pain. J Rheumatol 2000;27:772-8. (Comment) (Pubitemid 30151361)
60. Schnitzer TJ, Kamin M, Olson WH. Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: A randomized, double-blind, placebo-controlled study. Arthritis Rheum 1999;42:1370-7. (Pubitemid 30265594)
61. Sheather-Reid RB, Cohen M. Efficacy of analgesics in chronic pain: A series of N-of-1 studies. J Pain Symptom Manage 1998;15:244-52. (Pubitemid 28238679)
62. Silverfield JC, Kamin M, Wu SC, Rosenthal N; CAPSS-105 Study Group. Tramadol/acetaminophen combination tablets for the treatment of osteoarthritis flare pain: A multicenter, outpatient, randomized, double-blind, placebo-controlled, parallel-group, add-on study. Clin Ther 2002;24:282-97. (Pubitemid 34208422)
63. Simpson DM, Messina J, Xie F, Hale M. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: A multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 2007;29:588-601. (Pubitemid 47016640)
64. Sindrup SH, Andersen G, Madsen C, Smith T, Brosen K, Jensen TS. Tramadol relieves pain and allodynia in polyneuropathy: A randomised, double-blind, controlled trial. Pain 1999;83:85-90. (Pubitemid 29446160)
65. Thorne C, Beaulieu AD, Callaghan DJ, et al. A randomized, double-blind, crossover comparison of the efficacy and safety of oral controlled-release tramadol and placebo in patients with painful osteoarthritis. Pain Res Manag 2008;13:93-102. (Pubitemid 351865291)
66. Vlok GJ, van Vuren JP. Comparison of a standard ibuprofen treatment regimen with a new ibuprofen/paracetamol/codeine combination in chronic osteo-arthritis. S Afr Med J 1987;(Suppl 1):4-6.
67. Vorsanger GJ, Xiang J, Gana TJ, Pascual ML, Fleming RR. Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain. J Opioid Manag 2008;4:87-97. (Pubitemid 351836603)
68. Watson CP, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: A randomized controlled trial in painful diabetic neuropathy. Pain 2003;105:71-8. (Pubitemid 37162475)
69. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia. Neurology 1998;50:1837-41. (Pubitemid 28283261)
70. Webster LR, Butera PG, Moran LV, Wu N, Burns LH, Friedmann N. Oxytrex minimizes physical dependence while providing effective analgesia: A randomized controlled trial in low back pain 418. J Pain 2006;7:937-46. (Pubitemid 44854737)
71. Wu CL, Agarwal S, Tella PK, et al. Morphine versus mexiletine for treatment of postamputation pain: A randomized, placebo-controlled, crossover trial. Anesthesiology 2008;109:289-96.
72. Zautra AJ, Smith BW. Impact of controlled-release oxycodone on efficacy beliefs and coping efforts among osteoarthritis patients with moderate to severe pain. Clin J Pain 2005;21:471-7. (Pubitemid 41527735)
73. Katz N, Rauck R, Ahdieh H, et al. A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. Curr Med Res Opin 2007;23:117-28. (Pubitemid 46191677)
74. Vondrackova D, Leyendecker P, Meissner W, et al. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain. J Pain 2008;9:1144-54.
75. Nuesch E, Rutjes AW, Husni E, Welch V, Juni P. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev 2009;(4):CD003115.
76. Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010;(1):CD006605.
77. Leber PD, Davis CS. Threats to the validity of clinical trials employing enrichment strategies for sample selection. Control Clin Trials 1998;19:178-87. (Pubitemid 28191972)